NEW YORK, Oct. 26, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Dawson Geophysical Company ("Dawson" or the "Company") (NASDAQ: DWSN) in connection with the proposed acquisition of the Company by a subsidiary of Wilks Brothers, LLC ("Wilks Brothers"), via a tender offer. Under the terms of the merger agreement, the Company's shareholders will receive $2.34 per share in cash (the "Offer") for each share of Dawson common stock that they hold. Subject to the closing of the Offer, the merger agreement also contemplates that Wilks will acquire any Dawson shares that are not tendered into the Offer at the same price per share through a second-step merger, which will be completed as soon as practicable following the closing of the Offer, subject to the approval of at least 80% of the outstanding Dawson shares.
If you own Dawsonshares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
WeissLaw LLP is investigating whether (i) Dawson's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $2.34 per-share offer price adequately compensates Dawson's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, the merger consideration is $1.66 below the $4.00 median price targets set by analysts following the Company.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]